What's Hot

Image description

Kashi unveils new organic bars

Kashi recently introduced Organic Chewy Granola and Seed Bars. Made with a nutritious, plant-based blend of 100% whole grains, fruits, nuts and super seeds, Kashi Organic Chewy Granola and Seed Bars are free of highly refined sweeteners.

Image description

Natural beauty brand creates paper mask

One of the latest innovations from the Korean market has been face-shaped, paper sheet masks that hydrate skin and brighten the complexion. Natural skin and hair care brand Yes To has taken to this innovation and created the Yes To Grapefruit Pore Perfection Paper Mask infused with vitamin C, witch hazel, grapefruit and aloe leaf juice to help reduce hyperpigmentation, correct skin damage and enhance radiance.

Image description

TriCalm climbs the chart

Cosmederm Bioscience’s Tri-Calm OTC itch relief solution is quickly climbing the anti-itch treatment product chart with growth of 148.2% to a dollar base of $4.9 million for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI.

Image description

ZzzQuil rouses sleep aid category

When Procter & Gamble line extended its NyQuil brand identity into the sleep care aisle with the launch of ZzzQuil, the company did more than raise a few eyebrows. That launch awoke an entire category.

Image description

Flonase sales exceed competition

GlaxoSmithKline’s Flonase may not be on today’s top five bestselling cough-cold-allergy-sinus products list, but it won’t be long until the brand breaks through.

Image description

Nexium set to gain antacid market lead

Since the launch of Nexium 24HR in May of 2014, the brand has generated approximately $300 million, “making it one of the largest and most successful Rx-to-OTC switches,” Ian Read, Pfizer chairman and CEO, recently told analysts.

Image description

Tylenol poised to reclaim top spot

Tylenol has retaken the OTC pain relief aisle with a vengeance. The brand is close to reclaiming the top spot among internal analgesic tablets behind Aleve and Advil and is growing at a 10% rate on a dollar base of more than $250 million.